Compounds > n(1),n(11)-diethylnorspermine
Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Carcinoma, Transitional Cell

n(1),n(11)-diethylnorspermine has been researched along with Carcinoma, Transitional Cell in 2 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, BK1
Liang, Y1
Miller, DW1
Bergeron, RJ1
Porter, CW2
Wang, G1
Sharma, A1
Glaves, D1
Raghavan, D1
Bernacki, RJ1

Other Studies

2 other studies available for n(1),n(11)-diethylnorspermine and Carcinoma, Transitional Cell

ArticleYear
Effects of diethyl spermine analogues in human bladder cancer cell lines in culture.
    The Journal of urology, 1993, Volume: 150, Issue:4

    Topics: Carcinoma, Transitional Cell; Drug Screening Assays, Antitumor; Eflornithine; Humans; In Vitro Techn

1993
Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:8

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Division; Cell Survival; Humans;

1997